ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.

In March 2024 the patient clinical interaction assessment (PCIA) was communicated to stakeholders as a news item on the ANZCA website, which was also promoted through the ANZCA training e-newsletter.

Come join us in Cairns for learning, networking and socialising at the 2025 ANZCA ASM and FPM Symposium!

We are the leading clinical trials network in anaesthesia, pain and perioperative medicine. We have a clear focus to translate our research findings into practice to improve patient safety and care in our communities and globally.

Find out why we're a recognised world leader in training, education, research, and setting clinical standards for our specialties; what we're doing to foster safe and high quality patient care.

Access our calendar of clinical teaching courses; Learn@ANZCA; and the Training Resource Hub

The foundation dedicates around $1.5 million to medical research each year; supports our Indigenous health and overseas aid activities; and raises the profile of college-supported research.

Many of the recent advances in anaesthesia, pain medicine and perioperative patient care have involved pioneering ANZCA-funded research conducted by our fellows. Take a look at what we've achieved; what we fund; and how to apply.

We're responsible for setting the standards of clinical practice for anaesthesia and pain medicine in Australia and New Zealand. Our activities include issuing safety alerts; developing professional documents; and overseeing incident reporting.

The pain medicine training program comprises a minimum of two years clinical experience directly related to pain medicine, which allows specialists and those completing a speciality training program to become a specialist pain medicine physician.